Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization

• Asıl Yazarlar: Ahmed A Ghafar (Yazar), Elsayed Ghoneem (Yazar), Salah Rozaik (Yazar), Ahmed Akef (Yazar), Metwaly Mortada (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SpringerOpen, 2019-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background Transarterial chemoembolization (TACE), a locoregional therapy, is widely recommended as first-line treatment for intermediate-stage hepatocellular carcinoma (HCC). Several prognostic indices have been used to predict overall survival in HCC patients undergoing the procedure. Patients and...